Novartis Ag (NVS) Other Working Capital Changes (2022 - 2026)
Novartis Ag's Other Working Capital Changes history spans 5 years, with the latest figure at $346.0 million for Q1 2026.
- On a quarterly basis, Other Working Capital Changes rose 181.6% to $346.0 million in Q1 2026 year-over-year; TTM through Mar 2026 was -$147.0 million, a 82.1% increase, with the full-year FY2025 number at -$461.0 million, changed N/A from a year prior.
- Other Working Capital Changes hit $346.0 million in Q1 2026 for Novartis Ag, up from -$461.0 million in the prior quarter.
- Over the last five years, Other Working Capital Changes for NVS hit a ceiling of $392.0 million in Q3 2025 and a floor of -$461.0 million in Q4 2025.
- Historically, Other Working Capital Changes has averaged -$79.9 million across 5 years, with a median of -$79.5 million in 2022.
- The widest YoY moves for Other Working Capital Changes: up 853.85% in 2025, down 531.51% in 2025.
- Tracing NVS's Other Working Capital Changes over 5 years: stood at -$86.0 million in 2022, then soared by 118.6% to $16.0 million in 2023, then crashed by 556.25% to -$73.0 million in 2024, then crashed by 531.51% to -$461.0 million in 2025, then skyrocketed by 175.05% to $346.0 million in 2026.
- Business Quant data shows Other Working Capital Changes for NVS at $346.0 million in Q1 2026, -$461.0 million in Q4 2025, and $392.0 million in Q3 2025.